头颈鳞状细胞癌-话题@MedSci

#头颈鳞状细胞癌#

7篇内容 | 666人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1614096, encodeId=df95161409611, content=<a href='/topic/show?id=17244443870' target=_blank style='color:#2F92EE;'>#头颈鳞状细胞癌#</a>, objectTitle=J Clin Oncol：Afatinib（阿法替尼）联合Pembrolizumab（帕博利珠单抗）治疗复发或转移性头颈鳞状细胞癌（HNSCC）患者的疗效：ALPHA研究, objectType=article, longId=294454, objectId=3f302944546a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f302944546a, replyNumber=0, likeNumber=36, createdTime=2022-01-23, rootId=0, userName=ms55066533437992, userId=54d419484077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f302944546a, moduleTitle=J Clin Oncol：Afatinib（阿法替尼）联合Pembrolizumab（帕博利珠单抗）治疗复发或转移性头颈鳞状细胞癌（HNSCC）患者的疗效：ALPHA研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f302944546a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614095, encodeId=3d4d161409520, content=<a href='/topic/show?id=17244443870' target=_blank style='color:#2F92EE;'>#头颈鳞状细胞癌#</a>, objectTitle=Clin Cancer Res：派姆单抗联合Acalabrutinib治疗复发/转移性头颈鳞状细胞癌 , objectType=article, longId=221637, objectId=357d22163ea7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=357d22163ea7, replyNumber=0, likeNumber=32, createdTime=2021-12-08, rootId=0, userName=ms55066533437992, userId=54d419484077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=357d22163ea7, moduleTitle=Clin Cancer Res：派姆单抗联合Acalabrutinib治疗复发/转移性头颈鳞状细胞癌 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=357d22163ea7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614094, encodeId=b5741614094aa, content=<a href='/topic/show?id=17244443870' target=_blank style='color:#2F92EE;'>#头颈鳞状细胞癌#</a>, objectTitle=Lancet oncol：复发性/转移性头颈鳞状细胞癌患者的两种一线化疗方案对比！, objectType=article, longId=208161, objectId=dc7d20816104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc7d20816104, replyNumber=0, likeNumber=39, createdTime=2021-03-09, rootId=0, userName=ms55066533437992, userId=54d419484077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc7d20816104, moduleTitle=Lancet oncol：复发性/转移性头颈鳞状细胞癌患者的两种一线化疗方案对比！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc7d20816104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614093, encodeId=7d4916140937f, content=<a href='/topic/show?id=17244443870' target=_blank style='color:#2F92EE;'>#头颈鳞状细胞癌#</a>, objectTitle=Eur J Cancer：局部晚期头颈鳞状细胞癌老年患者强化放疗激活NBTXR3的I期剂量递增研究, objectType=article, longId=207381, objectId=313020e38117, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=313020e38117, replyNumber=0, likeNumber=29, createdTime=2021-02-22, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=313020e38117, moduleTitle=Eur J Cancer：局部晚期头颈鳞状细胞癌老年患者强化放疗激活NBTXR3的I期剂量递增研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=313020e38117)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614092, encodeId=b52516140925f, content=<a href='/topic/show?id=17244443870' target=_blank style='color:#2F92EE;'>#头颈鳞状细胞癌#</a>, objectTitle=J Dent Res：NOTCH通路在头颈鳞状细胞癌中的研究进展, objectType=article, longId=138851, objectId=d9ac138851b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9ac138851b0, replyNumber=0, likeNumber=33, createdTime=2018-05-24, rootId=0, userName=ms55066533437992, userId=54d419484077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9ac138851b0, moduleTitle=J Dent Res：NOTCH通路在头颈鳞状细胞癌中的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9ac138851b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614091, encodeId=74611614091a0, content=<a href='/topic/show?id=17244443870' target=_blank style='color:#2F92EE;'>#头颈鳞状细胞癌#</a>, objectTitle=J Dent Res：头颈鳞状细胞癌的精准医疗, objectType=article, longId=138791, objectId=1703138e91fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1703138e91fb, replyNumber=0, likeNumber=44, createdTime=2018-05-23, rootId=0, userName=ms55066533437992, userId=54d419484077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1703138e91fb, moduleTitle=J Dent Res：头颈鳞状细胞癌的精准医疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1703138e91fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614090, encodeId=11e816140901f, content=<a href='/topic/show?id=17244443870' target=_blank style='color:#2F92EE;'>#头颈鳞状细胞癌#</a>, objectTitle=NEJM：Nivolumab可延长复发性头颈鳞状细胞癌患者的总生存期, objectType=article, longId=79706, objectId=03fbe9706d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03fbe9706d9, replyNumber=0, likeNumber=39, createdTime=2016-10-12, rootId=0, userName=ms55066533437992, userId=54d419484077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03fbe9706d9, moduleTitle=NEJM：Nivolumab可延长复发性头颈鳞状细胞癌患者的总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03fbe9706d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

头颈鳞状细胞癌

2020-05-29

ms55066533437992 (审核中...)

前往app查看评论内容

#头颈鳞状细胞癌#

J Clin Oncol：Afatinib（阿法替尼）联合Pembrolizumab（帕博利珠单抗）治疗复发或转移性头颈鳞状细胞癌（HNSCC）患者的疗效：ALPHA研究

2022-01-23

ms55066533437992 (审核中...)

前往app查看评论内容

#头颈鳞状细胞癌#

Clin Cancer Res：派姆单抗联合Acalabrutinib治疗复发/转移性头颈鳞状细胞癌

2021-12-08

ms55066533437992 (审核中...)

前往app查看评论内容

#头颈鳞状细胞癌#

Lancet oncol：复发性/转移性头颈鳞状细胞癌患者的两种一线化疗方案对比！

2021-03-09

hb2008ye (审核中...)

前往app查看评论内容

#头颈鳞状细胞癌#

Eur J Cancer：局部晚期头颈鳞状细胞癌老年患者强化放疗激活NBTXR3的I期剂量递增研究

2021-02-22

ms55066533437992 (审核中...)

前往app查看评论内容

#头颈鳞状细胞癌#

J Dent Res：NOTCH通路在头颈鳞状细胞癌中的研究进展

2018-05-24

ms55066533437992 (审核中...)

前往app查看评论内容

#头颈鳞状细胞癌#

J Dent Res：头颈鳞状细胞癌的精准医疗

2018-05-23

ms55066533437992 (审核中...)

前往app查看评论内容

#头颈鳞状细胞癌#

NEJM：Nivolumab可延长复发性头颈鳞状细胞癌患者的总生存期

2016-10-12

科室
- - 订阅+
  - 更多科室
工具
服务